Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3

C A Meier1, C Parkison, A Chen

  • 1Molecular and Cellular Endocrinology Branch, National Institutes of Health, Bethesda, Maryland 20892.

Insights

Mutations in the human beta thyroid hormone receptor (h-TR beta) gene cause resistance to thyroid hormone. Mutant receptors show altered DNA binding and dominant negative effects that depend on the specific thyroid hormone response element (TRE).

Area of Science:

  • Molecular Endocrinology
  • Genetics
  • Cell Biology

Background:

  • Generalized resistance to thyroid hormone (GRTH) is linked to mutations in the human beta thyroid hormone receptor (h-TR beta) gene.
  • Understanding h-TR beta mutant interactions with response elements and retinoid X receptor beta (RXR beta) is crucial for GRTH pathogenesis.

Purpose of the Study:

  • To investigate the DNA binding interactions of three distinct h-TR beta 1 mutants (ED, OK, PV) with various thyroid hormone response elements (TREs).
  • To assess the influence of RXR beta on mutant h-TR beta 1 function and heterodimerization.
  • To determine the TRE-dependency of mutant receptor DNA binding and dominant negative potency.

Main Methods:

  • Analysis of mutant h-TR beta 1 homodimerization and heterodimerization with RXR beta on different TREs (TREpal, DR + 4, TRElap).
  • Measurement of T3-dependent receptor dissociation from TRElap.
  • Transient transfection studies in CV-1 and HeLa cells to evaluate dominant negative effects.

Main Results:

  • Mutant h-TR beta 1 receptors exhibited increased homodimerization and reduced T3-dependent dissociation from TRElap, proportional to T3 binding affinity.
  • While RXR beta formed heterodimers with mutants, the T3-dependent enhancement was reduced or absent.
  • Dominant negative potency was significantly higher on TRElap compared to TREpal or DR + 4, and RXR beta co-transfection did not reverse this effect.

Conclusions:

  • Mutant h-TR beta 1 DNA binding and dominant negative activity are dependent on the specific TRE sequence.
  • Competition for DNA binding, not limited RXR beta availability, likely mediates the dominant negative action of mutant h-TR beta 1 receptors in GRTH.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...